TauRx
TauRx is an England-based pharmaceutical company that develops and commercializes therapies for the treatment of neurodegenerative diseases.
Business Model:
Revenue: $10M
Employees: 51-200
Industries / Tags:
Detailed TauRx Information
Geographic Data
Address: 395 King Street
City: Aberdeen
State: england
Zip: AB24 5RP
Country: GB
Financial Info
Stage:
private equity
Raised Last:
$0
Raised Total:$258M
Social
Metrics
3,363,007Website Global Rank
4,401Website Monthly Traffic
Twitter Followers
Description
TauRx is an England-based pharmaceutical company that develops and commercializes therapies for the treatment of neurodegenerative diseases.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2012 | Unattributed | $31.5M |
Genting Management |
11/2012 | Venture Round | $0 |
Genting management Genting management Genting management Genting management |
11/2022 | Equity | $119M | 3/2022 | Private Equity Round | - |
Arcane Group Arcane Group |
11/2022 | Series A | $119M | 1/2016 | Private Equity Round | - | 10/2015 | Private Equity Round | $135M | 3/2013 | Private Equity Round | $0 |
Dundee Corporation Dundee Corporation Dundee Corporation Dundee Corporation |
3/2013 | Debt | 1 | $10.5M |
Dundee Corporation Dundee Corporation Dundee Corporation |
3/2022 | Private Equity Round | 1 | - |
Arcane Group Arcane Group |
1/2016 | Private Equity Round | - | 11/2012 | Venture Round | 1 | $112M |
Genting management Genting management Genting management Genting management |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
